Nephrology Doctors in Stockbridge, GA Accepting Medicare

7 Nephrology doctors found. Showing 1 - 7

Chadi Obeid, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3580 Cameron Parkway, Stockbridge, GA 30281 Phone: 770-996-6446    Fax: 770-996-6279

Leo Ovadje, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 105 N Park Trl, Suite 300, Stockbridge, GA 30281 Phone: 678-284-0800    Fax: 678-284-0393

Muhammed Hafiz Rahman, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 250 Village Center Pkwy, Suite 100, Stockbridge, GA 30281 Phone: 678-289-0508    Fax: 770-692-0301

Sanjay Sharma, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 250 Village Center Pkwy, Suite 100, Stockbridge, GA 30281 Phone: 678-289-0508    Fax: 770-692-0301

Jun-ki Park, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 105 N Park Trl, Ste. 300, Stockbridge, GA 30281 Phone: 678-284-0800    Fax: 678-284-9299

Dr. Mohamad M Kassem, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3580 Cameron Parkway, Stockbridge, GA 30281 Phone: 770-996-6446    Fax: 770-996-6279

Janice Latrice Weatherspoon, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 250 Village Center Pkwy, Stockbridge, GA 30281 Phone: 678-289-0508

News Archive

Anthrax, brucellosis and bovine TB fail to receive official recognition, say researchers

Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.

Study looks at effects of Ritalin on children with ADHD

When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.

Synta expands STA-9090 Phase 2 clinical trial in NSCLC

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it was expanding its Phase 2 clinical trial of STA-9090 in patients with Stage IIIB and Stage IV non-small cell lung cancer (NSCLC) from up to 69 patients to up to 146 patients based on encouraging activity observed in the first stage of the two stage clinical trial.

Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the submission of a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration for VELCADE® (bortezomib) for injection to add overall survival data after a five-year follow up to the product label.

Research: Divorce is linked to poor health outcomes, greater risk for early death

A growing body of research links divorce to a wide range of poor health outcomes, including greater risk for early death. However, the reason for the connection is not well understood.

Read more Medical News

› Verified 9 days ago